{"id":666322,"date":"2023-09-05T16:24:02","date_gmt":"2023-09-05T16:24:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=666322"},"modified":"2023-09-05T16:24:02","modified_gmt":"2023-09-05T16:24:02","slug":"astrocytoma-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/astrocytoma-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market_666322.html","title":{"rendered":"Astrocytoma Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1693897845.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Astrocytoma Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market\" src=\"https:\/\/www.abnewswire.com\/uploads\/1693897845.jpeg\" alt=\"Astrocytoma Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Astrocytoma Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Astrocytoma Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Astrocytoma, historical and forecasted epidemiology as well as the Astrocytoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">DelveInsight has launched a new report on&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astrocytoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Astrocytoma &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/a>&rdquo;.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astrocytoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Astrocytoma Market Report:<\/a><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to Hertz et al., 2020, a study aimed to compare the worldwide incidence rates of CNS cancers between 1990 and 2016 showed a 17.3% increase worldwide, reaching 32.5% for Western Europe. Furthermore, from a cohort of 264,241 pediatric and adult patients affected by various CNS tumors between 2003 and 2007, Leece et al., 2017, established that the incidence was 5.57\/100,000 for overall CNS tumors, and an average of 2.98\/100,000 for astrocytic tumors, which preferentially affected patients over 45 years of age.<\/li>\n<li>As per Crocetti et al., incidence rates for astrocytic tumors vary widely across European regions ranging from 3\/100,000 in Eastern Europe to 5\/100,000 in the United Kingdom and Ireland. Overall, an annual incidence rate of 4.8 per 100,000 for astrocytic cancers was estimated every year in Europe.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>Astrocytoma market report covers a descriptive overview and comprehensive insight of the Astrocytoma Epidemiology and Astrocytoma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Astrocytoma market report provides insights into the current and emerging therapies.<\/li>\n<li>Astrocytoma market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Astrocytoma market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Astrocytoma market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Astrocytoma Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">The brain is made up of various types of cells, including neurons, which constitute the electric circuitry responsible for brain functions, and astrocytes, which provide the structure and support for neurons to work properly. Astrocytoma is a type of cancer that can form in the brain or spinal cord. It begins in cells called astrocytes that support nerve cells, and are the most common brain tumors in adult individuals.<\/p>\n<p style=\"text-align: justify;\"><strong>Astrocytoma Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the&nbsp;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astrocytoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Astrocytoma market<\/a>&nbsp;<\/strong>are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as Denovo Biopharma, Orbus Therapeutics, Diffusion Pharmaceuticals, Tactical Therapeutics, Oncoceutics, and others during the forecasted period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><strong>Astrocytoma Pipeline Therapies and Key Companies&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>DB102 (Enzastaurin): Denovo Biopharma<\/li>\n<li>Eflornithine: Orbus Therapeutics<\/li>\n<li>Trans Sodium Crocetinate (TSC): Diffusion Pharmaceuticals<\/li>\n<li>Pravitinib (Carboxyamido Triazole Orotate): Tactical Therapeutics<\/li>\n<li>ONC201: Oncoceutics<\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li>And others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Astrocytoma Market Drivers&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Robust Pipeline Activity in the 7MM<\/li>\n<li>Improvement in technological advancements consumer education and awareness of Astrocytoma<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Astrocytoma Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Astrocytoma Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Astrocytoma Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Astrocytoma Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Astrocytoma&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Astrocytoma Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Astrocytoma Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Astrocytoma Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Astrocytoma Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Astrocytoma Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astrocytoma-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Astrocytoma Pipeline<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&#8220;Astrocytoma Pipeline Insight, 2023&#8221; report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Astrocytoma market. A detailed picture of the Astrocytoma pipeline landscape is provided, which includes the disease overview and Astrocytoma treatment guidelines.<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/astrocytoma-epidemiology-forecast?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Astrocytoma Epidemiology<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8216;Astrocytoma Epidemiology Forecast to 2032&#8217; report delivers an in-depth understanding of the disease, historical and forecasted Astrocytoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=astrocytoma-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91-9650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=astrocytoma-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrocytoma Market DelveInsight&#8217;s &#8220;Astrocytoma Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Astrocytoma, historical and forecasted epidemiology as well as the Astrocytoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/astrocytoma-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market_666322.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-666322","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/666322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=666322"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/666322\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=666322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=666322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=666322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}